Trial intelligence / Profile preview

Ketorolac 15 mg vs 60 mg for Acute Musculoskeletal Pain

NCT04763876Phase 4Completed

Sponsor
William Beaumont Army Medical Center
Start
Jun 2020
Primary completion
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketorolac in acute musculoskeletal pain, sponsored by William Beaumont Army Medical Center. Started Jun 2020; status: completed.

02

Drugs

ketorolac
03

Conditions

acute musculoskeletal pain

Beyond the preview

Go deeper on NCT04763876.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04763876.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call